Healthy Volunteer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Subjects who are voluntarily giving written informed consent. 2)Healthy males aged between 20 and 60. 3)Subjects who can eat test foods. 4)Subjects who can take meals, eat test foods, take blood samples, take urine samples and stay quiet and rest on the schedule indicated by investigators.
Exclusion criteria
Exclusion criteria: 1)Subjects whose clinical inspection results are outside of the normal range and who are estimated inappropriate to this study. 2)Subjects who have or had disorder in digestive, circulatory or endocrine system and who are estimated inappropriate to this study. 3)Subjects who take medicines for treatment of diseases. 4)Subjects who have allergy. 5)Subjects who are estimated inappropriate to this study by principal investigator or investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma concentration of SNR14 after single oral administration | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary excretion of SNR14 after single oral administration | — |
Countries
Japan
Contacts
Otsuka Pharmaceutical Co., Ltd. Saga Nutraceuticals Research Institute